Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models

PurposeMethods for estimating the excess mortality attributable to ventilator-associated pneumonia (VAP) should handle VAP as a time-dependent covariate, since the probability of experiencing VAP increases with the time on mechanical ventilation. VAP-attributable mortality (VAP-AM) varies with definitions, case-mix, causative microorganisms, and treatment adequacy. Our objectives here were to compare VAP-AM estimates obtained using a traditional cohort analysis, a multistate progressive disability model, and a matched-cohort analysis; and to compare VAP-AM estimates according to VAP characteristics.MethodsWe used data from 2,873 mechanically ventilated patients in the Outcomerea® database. Among these patients from 12 intensive care units, 434 (15.1%) experienced VAP; of the remaining patients, 1,969 (68.5%) were discharged alive and 470 (16.4%) died. With the multistate model, VAP-AM was 8.1% (95% confidence interval [95%CI], 3.1–13.1%) for 120 days’ complete observation, compared to 10.4% (5.6–24.5%) using a matched-cohort approach (2,769 patients) with matching on mechanical ventilation duration followed by conditional logistic regression. VAP-AM was higher in surgical patients and patients with intermediate (but not high) Simplified Acute Physiologic Score II values at ICU admission. VAP-AM was significantly influenced by time to VAP but not by resistance of causative microorganisms. Higher Logistic Organ Dysfunction score at VAP onset dramatically increased VAP-AM (to 31.9% in patients with scores above 7).ConclusionA multistate model that appropriately handled VAP as a time-dependent event produced lower VAP-AM values than conditional logistic regression. VAP-AM varied widely with case-mix. Disease severity at VAP onset markedly influenced VAP-AM; this may contribute to the variability of previous estimates.

[1]  Corinne Alberti,et al.  Calibration and discrimination by daily Logistic Organ Dysfunction scoring comparatively with daily Sequential Organ Failure Assessment scoring for predicting hospital mortality in critically ill patients* , 2002, Critical care medicine.

[2]  Yves Cohen,et al.  Predicting the risk of documented ventilator-associated pneumonia for benchmarking: Construction and validation of a score* , 2009, Critical care medicine.

[3]  M. Schumacher,et al.  Use of Multistate Models to Assess Prolongation of Intensive Care Unit Stay Due to Nosocomial Infection , 2006, Infection Control & Hospital Epidemiology.

[4]  Jean-Yves Fagon,et al.  Ventilator-associated pneumonia. , 2002, American journal of respiratory and critical care medicine.

[5]  S. Chevret.  Logistic or Cox model to identify risk factors of nosocomial infection: still a controversial issue , 2001, Intensive Care Medicine.

[6]  M. Wolff,et al.  Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. , 2000, American journal of respiratory and critical care medicine.

[7]  R. Fernandez,et al.  Excess ICU mortality attributable to ventilator-associated pneumonia: The role of early vs late onset , 2007, Intensive Care Medicine.

[8]  J. Rello,et al.  The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia. , 2008, Chest.

[9]  C. Clec’h,et al.  Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A Bueno-Cavanillas,et al.  Influence of nosocomial infection on mortality rate in an intensive care unit , 1994, Critical care medicine.

[11]  N. Keiding,et al.  Multi-state models for event history analysis , 2002, Statistical methods in medical research.

[12]  F. Saulnier,et al.  Impact of ventilator-associated pneumonia on outcome in patients with COPD. , 2005, Chest.

[13]  L. Brochard,et al.  Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis. , 1997, American journal of respiratory and critical care medicine.

[14]  M Schumacher,et al.  Attributable Mortality due to Nosocomial Infections , 2007, Methods of Information in Medicine.

[15]  F. Rojo,et al.  Overexpression of the Multidrug Efflux Pumps MexCD-OprJ and MexEF-OprN Is Associated with a Reduction of Type III Secretion in Pseudomonas aeruginosa , 2005, Journal of bacteriology.

[16]  Sanjay Saint,et al.  Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.

[17]  Martin Schumacher,et al.  Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models , 2008, Critical care.

[18]  Yves Cohen,et al.  Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study , 2002, Intensive Care Medicine.

[19]  Jean-Yves Fagon,et al.  Ventilator-associated pneumonia. , 2002 .

[20]  M. Kollef,et al.  A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. , 2000, Chest.

[21]  H. Sax,et al.  Ventilator-associated pneumonia as a quality indicator for patient safety? , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  A. Combes,et al.  Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. , 2004, American journal of respiratory and critical care medicine.

[23]  E. Haponik,et al.  Pneumonia in intubated trauma patients. Microbiology and outcomes. , 1996, American journal of respiratory and critical care medicine.

[24]  M. Rovers,et al.  Ventilator‐associated pneumonia and mortality: A systematic review of observational studies * , 2009, Critical care medicine.

[25]  R. Wunderink,et al.  Ventilator-associated pneumonia due to Pseudomonas aeruginosa. , 1996, Chest.

[26]  R. Platt,et al.  Ventilator-Associated PneumoniaThe Wrong Quality Measure for Benchmarking , 2007, Annals of Internal Medicine.

[27]  Martin Schumacher,et al.  The impact of time‐dependent bias in proportional hazards modelling , 2008, Statistics in medicine.

[28]  M. Schumacher,et al.  Modeling the effect of time-dependent exposure on intensive care unit mortality , 2009, Intensive Care Medicine.

[29]  David Schoenfeld,et al.  Survival methods, including those using competing risk analysis, are not appropriate for intensive care unit outcome studies , 2005, Critical care.

[30]  J. Timsit.  Bronchoalveolar lavage for VAP diagnosis: patients must be sampled before any change of antimicrobial therapy , 2007, Intensive Care Medicine.

[31]  Corinne Alberti,et al.  Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity , 2004, Intensive Care Medicine.

[32]  M. Klompas.  Does this patient have ventilator-associated pneumonia? , 2007, JAMA.

[33]  D. Cook,et al.  The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.

[34]  M. Kollef,et al.  The effect of late-onset ventilator-associated pneumonia in determining patient mortality. , 1995, Chest.

[35]  A. Harris,et al.  Risk of mortality with a bloodstream infection is higher in the less severely ill at admission. , 2005, American journal of respiratory and critical care medicine.

[36]  W E Barlow,et al.  Analysis of case-cohort designs. , 1999, Journal of clinical epidemiology.